Merck Completes Sale of Generics Business to Mylan for EUR 4.9 Billion
05-Oct-2007
Proceeds of the sale will be booked in the fourth quarter. As previously announced Merck intends to use the funds to pay down debt.
As part of the transaction, Mylan has the right to use the Merck name in connection with the acquired business for a transitional period of up to two years after closing.
Merck Generics generated EUR 1,819 million of sales in 2006 and had nearly 5,000 employees.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Alcoa Appoints Two New Directors; Stan O'Neal and Michael G. Morris to Join Company Board of Directors
Go to page
FiltraGuide - Re-launch of website
Go to page
Eastman Increases Isophthalic Acid Prices
Go to page
Eastman to Expand Hydrogenated Hydrocarbon Resin Production in Middelburg, The Netherlands
Go to page
QuestAir named one of Canada's fastest growing technology companies in 2006 Deloitte Technology Fast 50 Program
Go to page